Exdensur Patient Assistance Program

(depemokimab-ulaa)

Key Takeaways

  1. Exdensur® (depemokimab-ulaa) is a prescription biologic medication used as an add-on maintenance treatment for severe eosinophilic asthma in adults and pediatric patients 12 years of age and older.
  2. Exdensur works by blocking interleukin-5 (IL-5), reducing eosinophil levels that contribute to airway inflammation and severe asthma attacks.
  3. As the first FDA-approved asthma biologic administered only once every six months, Exdensur offers a convenient long-term treatment option for eligible patients.
  4. Prescription Hope may help eligible individuals access manufacturer-sponsored patient assistance programs that can make Exdensur more affordable.

 

Introduction

Managing severe eosinophilic asthma can be challenging, particularly when symptoms remain uncontrolled despite the use of standard maintenance medications. Frequent asthma attacks, emergency care visits, and ongoing inflammation can significantly affect daily activities and overall quality of life. For some patients, biologic therapies provide a targeted treatment option that addresses one of the underlying causes of severe asthma.

Exdensur is a prescription biologic medication approved as an add-on maintenance treatment for adults and pediatric patients 12 years of age and older with severe asthma and an eosinophilic phenotype. By targeting interleukin-5 (IL-5), Exdensur helps reduce eosinophil-driven airway inflammation, lowering the risk of severe asthma exacerbations while supporting long-term asthma control.

As a newly approved specialty biologic, Exdensur may be expensive depending on insurance coverage and available financial assistance. Many patients researching the Exdensur patient assistance program are looking for ways to reduce out-of-pocket medication costs while maintaining access to treatment.

Prescription Hope offers advocacy and support for patients looking to save on medication costs through patient assistance programs.

 

What Is the Exdensur Patient Assistance Program?

Understanding Exdensur Prescription Assistance

Many Americans struggle to afford their brand-name medications due to high retail costs, inadequate insurance, and heavy financial burdens.

Pharmaceutical manufacturers understand this and have developed a powerful solution. Patient Assistance programs provide access to affordable medications for qualified patients.

While beneficial, some patient assistance programs have been known to have difficult application processes. Patients feel frustrated and often quit before finishing.

Thankfully, Prescription Hope is here to help.

 

How Expert Advocates Help Make Exdensur More Affordable

Personalized Medication Assistance

Prescription Hope offers support and advocacy for patients wanting to apply for patient assistance programs. Our prescription assistance specialists help Americans every day get access to the affordable medications they need every month.

 

Ongoing Patient Support

Not only does Prescription Hope offer patient assistance, but we also provide long-term medication assistance. Our team of patient advocates manages refill scheduling, document updates, yearly renewals, and more, for as long as a patient is with us.

 

Navigating Severe Asthma Treatment Costs

Our prescription access solutions are a simple $70.00 per month, per medication. No matter the medication’s cost, our patients only pay $70.00 per month, per medication. We do not include add-on fees, hidden charges, or variable pricing systems.

And if a patient does not qualify, we’ll work to find other ways to save. We’ve helped patients access substitute medication programs, discount cards, coupons, and more.

Plus, if we can’t help a patient save, then they pay nothing.

Exdensur Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$25,404.70

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Exdensur Patient Assistance Eligibility

General Eligibility Requirements

Wondering whether you meet the Exdensur patient assistance qualifications?

All manufacturers set strict qualifications for their patient assistance programs. However, requirements typically fall into several general categories, such as:

Income: Income threshold varies from program to program.

Insurance: Insurance coverage status also varies between programs.

U.S. Residency: All qualified patients must be legal U.S. residents.

Prescription: All qualified patients must have a valid prescription for the medication they wish to access.

 

Simple Enrollment With Expert Support

Getting Started With Enrollment

Ready to enroll in Exdensur assistance? The Exdensur application process through Prescription Hope is as easy as 6 simple steps:

  1. Submit Information: Prescription Hope’s enrollment forms only take a few minutes to complete.
  2. Advocate Contact: Once we receive your enrollment form, a patient advocate will reach out within 1-2 business days.
  3. Document Collection: After you pass our quick prequalification, our team will collect all needed documents.
  4. Provider Coordination: Our staff will also collect all necessary signatures.
  5. Program Submission: We then submit your completed application to the manufacturer and continue to coordinate with them throughout the entire process.
  6. Medication Delivery: After approval, the manufacturer will ship your medication directly to your door or doctor’s office. Patients typically receive their medications within 2 weeks.

Prescription Hope is not a pharmacy or manufacturer and does not handle medications at any time.

 

Understanding Exdensur

How Exdensur Works

Exdensur is an interleukin-5 (IL-5) antagonist monoclonal antibody that helps reduce eosinophilic inflammation associated with certain forms of severe asthma. IL-5 is a protein that promotes the growth, activation, and survival of eosinophils, a type of white blood cell involved in airway inflammation.

By blocking IL-5, Exdensur lowers eosinophil levels throughout the body, helping decrease airway inflammation that contributes to severe asthma exacerbations. Reducing eosinophil activity may improve long-term asthma control and decrease the frequency of severe asthma attacks in appropriate patients.

Exdensur has an extended half-life that allows for administration only once every six months. This twice-yearly dosing schedule makes it the first FDA-approved biologic for asthma with such an extended dosing interval, offering a convenient maintenance treatment option for eligible patients.

 

What Conditions Does Exdensur Treat?

Exdensur is FDA-approved as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adults and pediatric patients 12 years of age and older whose asthma remains uncontrolled despite appropriate maintenance therapy.

Severe eosinophilic asthma is a subtype of asthma characterized by elevated eosinophil levels that contribute to chronic airway inflammation and recurrent asthma exacerbations. Patients with this condition may continue to experience symptoms and severe attacks despite treatment with inhaled corticosteroids and other controller medications.

Exdensur is intended to be used alongside existing maintenance asthma therapies. It is not a rescue medication and should not be used to treat acute bronchospasm, sudden asthma attacks, or status asthmaticus.

 

Benefits of Treatment

Exdensur provides a targeted treatment option for patients with severe eosinophilic asthma by reducing eosinophil-driven airway inflammation. By addressing an important inflammatory pathway, treatment may help lower the risk of severe asthma exacerbations while improving long-term asthma control.

Potential benefits of Exdensur include reducing severe asthma attacks, decreasing the need for emergency department visits and hospitalizations related to asthma, supporting improved symptom control, and helping patients whose asthma remains uncontrolled on standard maintenance therapy. Its twice-yearly dosing schedule also offers the convenience of only two healthcare-administered injections each year.

Individual treatment outcomes vary. Patients should continue taking all prescribed maintenance asthma medications unless their healthcare provider advises otherwise, and routine follow-up visits remain important for monitoring treatment response.

 

Important Safety Information and Side Effects

Exdensur does not carry an FDA Boxed Warning.

The most commonly reported side effects include upper respiratory tract infection, allergic rhinitis, influenza, joint pain (arthralgia), and sore throat (pharyngitis). Patients should notify their healthcare provider if side effects become severe, persistent, or concerning.

Serious hypersensitivity reactions, including anaphylaxis, can occur after administration of Exdensur. Patients should seek emergency medical attention if they develop symptoms such as swelling of the face, lips, mouth, or tongue, difficulty breathing, hives, rash, dizziness, or fainting.

Exdensur is not intended to treat acute asthma attacks, acute bronchospasm, or status asthmaticus. Patients should continue carrying and using their prescribed rescue inhaler for sudden breathing symptoms and seek emergency medical care when appropriate.

Patients should not abruptly stop taking oral or inhaled corticosteroids after beginning Exdensur therapy. Any reduction in corticosteroid dosage should occur only under the supervision of a healthcare provider.

Patients with known parasitic (helminth) infections should receive appropriate treatment before starting Exdensur whenever possible. If a patient develops a parasitic infection that does not respond to treatment while receiving Exdensur, temporary interruption of therapy may be considered until the infection resolves.

Limited information is available regarding the use of Exdensur during pregnancy and breastfeeding. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential benefits and risks with their healthcare provider before starting treatment.

No clinically significant drug interactions are identified in the FDA-approved prescribing information. However, patients should tell their healthcare provider about all prescription medications, over-the-counter products, vitamins, and herbal supplements they use before beginning treatment.

Exdensur is administered as a subcutaneous injection by a healthcare professional once every six months. Injection sites include the upper arm, thigh, or abdomen. Patients should continue prescribed maintenance asthma medications, attend scheduled follow-up visits, and be monitored for asthma symptom control, treatment response, hypersensitivity reactions, asthma exacerbations, and ongoing need for oral corticosteroids.

 

Access to Multiple Medications

Support Beyond Exdensur

Those in need of specialty medication access often need multiple medication assistance programs for the other medications they’re taking.

Prescription Hope’s list of hundreds of accessible medications means we can provide service for every medication you qualify for.

And our service rate remains a simple and clear $70.00 per month, per medication. We manage your application process from start to finish, as well as all administrative tasks, for each medication you qualify for, as long as you are a patient with us.

 

Why Choose Prescription Hope for Medication Assistance

Patient-Focused Medication Support

For 20 years, patients have trusted Prescription Hope’s team of expert patient advocates with their medication access. And for two decades, Prescription Hope’s patients have enjoyed access to their meds for a simple service rate.

 

Simplified Access to Specialty Therapies

Our service rate is a simple $70.00 per month, per medication. We’re proud to offer a simple, worry-free service rate that lowers your medication costs and allows you to focus on the things that matter in life.

 

Ongoing Prescription Assistance

Our prescription assistance help continues long after a patient receives approval and their initial shipment of medications. We manage the administrative tasks related to keeping your program in accepted status.

If you’re looking for long-term medication support and would like to apply for the Exdensur Patient Assistance Program, then be sure to enroll with Prescription Hope today!

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!